| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 9e-08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.29 | 2e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |